OS Therapies Ownership
| OSTX Stock | 3.02 1.44 32.29% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
OSTX |
OSTX Stock Ownership Analysis
About 25.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.32. OS Therapies had not issued any dividends in recent years. To find out more about OS Therapies Incorporated contact the company at 410-297-7793 or learn more at https://ostherapies.com.OS Therapies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OS Therapies insiders, such as employees or executives, is commonly permitted as long as it does not rely on OS Therapies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OS Therapies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mckean-dieser Avril Suzette over a month ago Insider Trading | ||
Mckean-dieser Avril Suzette over a month ago Insider Trading | ||
Ciccio John over three months ago Acquisition by Ciccio John of 266306 shares of OS THERAPIES at 75000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Ciccio John over three months ago Acquisition by Ciccio John of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Acevedo Christopher P. over three months ago Disposition of tradable shares by Acevedo Christopher P. of OS THERAPIES subject to Rule 16b-3 |
OS Therapies Corporate Filings
| 27th of November 2024 Other Reports | ViewVerify | |
10Q | 15th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 14th of November 2024 Other Reports | ViewVerify | |
S1 | 12th of November 2024 Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.